Veterinary Pain Management Market Anticipated to Grow at an Impressive Rate during the Forecast Period
However, lack of awareness towards serious disease conditions in companion animals restrains the growth of the market. On the contrary, increase in popularity of nonconventional and non-pharmaceutical treatment techniques and untapped emerging markets are anticipated to provide potential growth opportunity for the market.
Veterinary pain management is a crucial part of veterinary therapeutics. Pain not addressed appropriately in animals leads to delayed healing and exaggerated stress in already sick animals. Pain in animals could be due to surgeries, arthritis, and cancer that is accompanied with loss of appetite, aggression, and reduced activity. This could hinder the productivity of farm and pet animals. Ongoing research on lowering chronic pain in animals has made multiple options available to treat various causes of pain in animals that include pain medications, physical rehabilitation, acupuncture, laser therapy, and therapeutic massage.
Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-toc-and-sample/4656
The global veterinary pain management market is segmented on the basis of product, application, distribution channel, and region. By product, the market is differentiated into drugs and devices. Based on application, it is categorized into postoperative, cancer, arthritis, and others. Depending on distribution channel, it is divided into hospitals & clinics and pharmacy. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Spain, Italy, and rest of Europe), Asia pacific (Japan, China, Singapore, India, South Korea, and rest of Asia-Pacific), LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA)
The key players of operating in the market are Bayer AG, Boehringer Ingelheim International GmbH., Merck & Co., Inc., The Chanelle Group, Norbrook Laboratories Limited, Eli Lilly and Company, Inc., Dechra Pharmaceuticals PLC., Ceva Sante Animale, IDEXX Laboratories, Inc., and Zoetis.
Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/4656
• The report provides a quantitative analysis of the current market and estimation through 20172025 that assists to identify the current market opportunities.
• The report contains a thorough analysis of the factors that drive and restrict the growth of the global veterinary pain management market.
• The projections in the report are made by analyzing the current and future market trends for a period of 20172025.
• In-depth analysis of drug types helps to understand the different types of drugs used for pain management in animals.
• Comprehensive analysis of the geographic regions is provided, which helps to better understand the region wise growth.
• Key players within the global veterinary pain management market are profiled to understand the competitor scenario.
Access Full Summery @ https://www.alliedmarketresearch.com/veterinary-pain-management-market
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Veterinary Pain Management Market Anticipated to Grow at an Impressive Rate during the Forecast Period here
News-ID: 1780698 • Views: 211
More Releases from Allied Market Research
North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently
More Releases for Pain
Global Pain Management Drugs & Devices Market By Application - Burn Pain, Cancer …
Researchmoz added Most up-to-date research on "Global Pain Management Drugs & Devices Market By Application - Burn Pain, Cancer Pain, Dental/Facial Pain, Migraine Headache Pain & Musculoskeletal Pain" to its huge collection of research reports. This report studies Pain Management Drugs & Devices in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016,
Pain Management Devices Market
ReportsWorldwide has announced the addition of a new report title Pain Management Devices Market to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/pain-management-devices-market More than 100 million people in the US experience chronic pain. In Europe, the prevalence of chronic pain is between 25% and 35%. Pain-related disability represents a significant and costly liability to patients
Boot chronic pain
For immediate release Due to our rushed lives and stressful environment, many people are suffering from chronic pain and fatigue. We feel permanently tired and are barely able to get through our normal day. One is able to change this status when following the guidelines the book "Tired of being Tired to the point of being Gatvol (Fed Up). Some people will need a team of medical practitioners to help them
Targeting chronic pain
With the support of the Austrian Science Fund FWF, the neurophysiologist Ruth Drdla-Schutting is investigating the role astrocytes play in the genesis of chronic pain. With the help of innovative gene technology (DREADDs), scientists are tailoring treatment specifically to these cells that are the most numerous found in the central nervous system. Pain is an important protection system of the human body. But when it becomes chronic, as it frequently
Complex Regional Pain Syndrome
“Complex Regional Pain Syndrome Global 2016 Clinical Trials Review, H2" provides an detailed overview of Complex Regional Pain Syndrome scenario. Report includes top line data relating on Complex Regional Pain Syndrome Global clinical trials scenario. This report on Complex Regional Pain Syndrome also includes an review of trial numbers as well as their ( Complex Regional Pain Syndrome ) average enrollment in uppermost/top countries which are conducted worldwide. Complex Regional
Orthovisc- No More Pain
Orthovisc is a Hyaluronan formulation which stands effective in curing the knee joint pain. Joint pain caused due to osteoarthritis often keeps away people from taking part or enjoying a lot of things physically. Suffering from knee pain can create a lot of troubles in the life of the person suffering from it. In medical science, osteoarthritis is considered one of the most dreaded diseases which create a lot of